Nine quinolone alkaloids (1-9) from the fruits of Evodia rutaecarpa were investigated for their inhibitory activity on nuclear factor of activated T cells (NFAT)-dependent transcription in comparison with nuclear factor (NF)-k kB-dependent transcription using a reporter gene assay. These alkaloids showed inhibitory effects against NFAT activity, with IC 50 values between 0.91 m mM and 15.91 m mM. Of the N-methylated quinolones, the longer aliphatic side chain at the quinolone ring showed stronger inhibition of NFAT activity. These N-methylated compounds showed comparable inhibitory effects against NF-k kB activity. However, quinolone alkaloids without the N-methyl group showed a more selective inhibition of NFAT activity.
Nuclear factor of activated T cells (NFAT) proteins are expressed in most immune system cells and regulate the transcription of cytokine genes critical for the immune response. The activity of NFAT proteins is tightly regulated by the Ca 2ϩ /calmodulin-dependent protein phosphatase 2B/calcineurin (CaN). Dephosphorylation of NFAT by CaN is required for NFAT nuclear localization, and then in the nucleus NFAT activates the transcription of target genes, such as interleukin-2, -3, -4, -5, -8, -13, tumor necrosis factor-a, granulocyte-macrophage colony-stimulating factor, and g-IFN.
1, 2) Normally activation of NFAT plays a key role in regulating a large number of inducible genes during the immune response.
3) However, excessive activation provokes immunopathologic reactions including autoimmunity, transplant rejection, and inflammation. 4) Current immunosuppressive drugs such as cyclosporin A (CsA) and FK506 block CaN activity, thus inhibiting nuclear translocation of NFAT and consequent cytokine gene transcription. 5) Both CsA and FK506 have been effective in preventing organ graft rejection in the clinic. However, side effects observed with the clinical use of both of these compounds and gastrointestinal toxicity have markedly reduced their impact. 6) In a searching for inhibitors of NFAT activity from natural products, the MeOH extract of the fruits of Evodia rutaecarpa showed significant inhibitory activity of NFAT as assessed by a reporter gene assay. Here we describe the isolation and effects of three known quinolone alkaloids (1-3) together with other quinolone alkaloids (4-9) from the Evodia fruits on the activities of NFAT and nuclear factor (NF)-kB.
MATERIALS AND METHODS

Plant Material
The dried unripe fruits of E. rutaecarpa were purchased from an herbal drug market in Daejeon and the authenticity was confirmed by Y. H. Kim, College of Pharmacy, Chungnam National University. A voucher specimen (No. 01908) has been deposited in the Korea Research Institute of Bioscience and Biotechnology.
General Experimental Procedures Melting points were measured on an Electrothermal 9100 instrument without correction. Optical rotations were measured on a JASCO DIP-370 polarimeter. UV spectra were obtained on a Milton Roy 3000 spectrometer. IR spectra were determined on a JASCO Report-100 spectrometer (KBr plate). ESI-MS was obtained on a Platform quadrupole mass spectrometer. Cell Lines and Cell Culture Jurkat T cell lines were maintained in RPMI 1640 medium, and RAW264.7 cells were maintained in DMEM medium. Both media were supplemented with penicillin (100 units/ml), streptomycin (100 units/ml) (Invitrogen), and 10% heat-inactivated fetal bovine serum (Hyclone). Phorbol 12-myristate 13-acetate (PMA) and Ca 2ϩ ionophore A23187 were obtained from Sigma Chemical Co.
NFAT Activity Assay A pNFAT-Luc plasmid for the NFAT-dependent luciferase reporter assay was obtained from Stratagene (La Jolla, CA, U.S.A.). Transfections in Jurkat T cells were performed using LipofectAMINE Plus reagent according to the manufacturer's protocol (Invitrogen). Twentyfour hours after transfection, the cells were treated with various concentrations of test compounds for 30 min and then stimulated with PMA (10 ng/ml) and Ca 2ϩ ionophore A23187 (1 mM). After stimulation, the cells were further incubated for 24 h, and then the luciferase assay was performed using a luciferase assay system according to the manufacturer's instructions (Promega, Madison, WI, U.S.A.). Luciferase activity was determined in a Microlumat Plus luminometer (EG&G Berthold, Bad Wildbad, Germany) by injecting 100 ml of assay buffer containing luciferin and measuring light emission for 10 s. The results were normalized to the activity of b-galactosidase expressed by cotransfected lacZ gene under the control of a constitutive promoter.
NF-k kB Activity Assay NF-kB activity was determined as previously described. 7) RAW264.7 cells stably transfected with a plasmid containing eight copies of kB elements linked to the secreted alkaline phosphatase (SEAP) gene were used.
Extraction and Isolation The fruits of E. rutaecarpa (5 kg) were extracted three times at room temperature with methanol. The MeOH extract (520.8 g) was partitioned between H 2 1 H-NMR (300 MHz, CDCl 3 ) and 13 C-NMR (75 MHz, CDCl 3 ) spectra and physical constants were identical to those in a previous report.
8) The other quinolone alkaloids 4-9 were previously reported 10) and their purity were more than 98% in HPLC analysis.
RESULTS AND DISCUSSION
Three known quinolone alkaloids (1-3) were isolated from the ethyl acetate-soluble fraction by repeated column chromatography and preparative HPLC. As shown in Fig. 1 , the structures of these compounds were identified by comparing physiochemical and spectroscopic data with previously reported results as 2-nonyl-4(1H)-quinolone (1), 1-methyl-2-nonyl-4(1H)-quinolone (2), and 2-undecyl-4(1H)-quinolone (3). 8, 9) Knowing the inhibitory activities of quinolone alkaloids 1-3, we examined the effects of these compounds on NFAT-dependent transcription together with those of other quinolone alkaloids from Evodia fruits (4-9) (Fig. 1) , which have previously been reported to have antiHelicobacter pylori activity (Table 1) .
10) The immunosuppressant CsA, as a positive control, strongly inhibited the induced NFAT transcription, with an IC 50 value of 1.0 nM. Quinolone alkaloids 1-9 showed significant inhibitory effects on the induced NFAT activation by PMA and Ca 1.86 mM, 6 vs. 9; 6: 0.91 mM, 9: 1.01 mM) suggested that the presence of double bonds could improve the inhibitory effect on NFAT activity in the compounds with a chain length of 13 carbons, although not in those with 15 carbons. Therefore we could not state the significance of the degree of unsaturation of the side chain on NFAT activity without a systematic comparison with more compounds. It has been known not only that NFAT and NF-kB compete for binding to the DNA binding site but also that the NFAT DNA binding domain shows a strong structural similarity to that of NF-kB, which also plays a critical role in the immune and inflammatory re- sponses. 3, 11) We investigated the effect of compounds 1-9 on LPS-induced NF-kB activation in RAW264.7 cells. Except for compounds 1 and 3, the other compounds significantly inhibited LPS-induced NF-kB activation. However, we did not find a correlation between the inhibitory activity and the length of side chain and number of double bonds in the compounds on the NF-kB activity. Interestingly, both compounds 1 and 3, which lack on N-methyl group in the quinolone ring, did not inhibit NF-kB activity significantly but they showed much more potent inhibitory activity against NFAT activity than N-methylated compounds 2 and 4. Although the structure-activity relationship between N-methylated and N-demethylated quinolones was not conclusively demonstrated due to having only two pairs of compounds, it is likely that the absence of an N-methyl group in the quinolone ring would be an important factor in a selective inhibitory effect on NFAT transcription. In conclusion, novel inhibitors with a quinolone skeleton may lead to the development of new therapies for the treatment of autoimmune disease and transplant rejection.
